Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

neurologylive.com image

News from neurologylive.com

See all of neurologylive.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

We’ve discovered 390 headlines written by neurologylive.com during the past 3 months.

Ground News rates neurologylive.com’s media bias as unknown. . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

neurologylive.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about neurologylive.com

Where is neurologylive.com located?neurologylive.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top neurologylive.com News

Clinical trial significantly improves detection of hidden blood clots in stroke patients

Medical · London

Clinical trial significantly improves detection of hidden blood clots in stroke patients

75% Right coverage: 4 sources

A clinical trial led by London Health Sciences Centre Research Institute (LHSCRI) and Western University's Schulich School of Medicine & Dentistry may enhance how medical professionals detect hidden blood clots responsible for strokes.See the Story

Pregnancy: No Reason Not to Treat Migraine

European Parliament

Pregnancy: No Reason Not to Treat Migraine

100% Right coverage: 1 sources

Sumatriptan and onabotulinumtoxinA are safe options during pregnancy.See the Story

Rheumatology Indication Looks Promising for Efgartigimod

Barcelona · Barcelona

Rheumatology Indication Looks Promising for Efgartigimod

100% Center coverage: 1 sources

(MedPage Today) -- BARCELONA -- A drug targeting immunoglobulin G (IgG) currently approved for myasthenia gravis and chronic inflammatory demyelinating polyneuropathy (CIDP) now looks like it could take the rheumatology field by storm, if phase...See the Story

FDA Accelerated Approval Open for FSHD Agent Del-Brax, With Newly Initiated Phase 3 Study to Confirm Efficacy

Avidity Biosciences advances del-brax for FSHD, initiating a pivotal Phase 3 study while exploring accelerated FDA approval pathways.United States · United States Read Article

Insights on NervGen Pharma’s Positive Phase 1b/2a Data for NVG-291 in Spinal Cord Injury

Daniel Mikol, MD, PhD, chief medical officer at NervGen Pharma, provided clinical perspective on recently announced positive findings from a phase 1b/2a trial testing NVG-291 as a treatment for spinal cord injury.Maryland · Maryland Read Article

Once-Nightly Oxybate Reduces Sleep-Related Eating, Samelisant Improves Excessive Daytime Sleepiness, Tirzepatide's Impact on OSA and Obesity

Neurology News Network. for the week ending June 14, 2025. [WATCH TIME: 4 minutes]Read Article

Advances in Therapeutics and Imaging from European Stroke Organization Conference 2025: Kevin Sheth, MD

The director of the Center for Brain and Mind Health at Yale University discussed new findings in thrombolytic therapy, stroke monitoring, neuroprotection, and imaging technologies presented at ESOC 2025. [WATCH TIME: 7 minutes]Maryland · Maryland Read Article

Looking at the Importance of Family-Centered Care Approaches in Pediatric Sleep Medicine

Funke Afolabi-Brown, MD, FAASM, chief executive officer of Restful Sleep MD, discussed the potential role of family dynamics and individualized planning in the effective management of pediatric sleep disorders.Read Article

Episode 143: Bemdaneprocel and the Future of Cell Therapy in Parkinson Disease

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Rajesh Pahwa, MD. [LISTEN TIME: 15 minutes]Podcast · Maryland Read Article

Phase 2 Study to Test Therapeutic Potential of Samelisant for Narcolepsy Type 1

The trial of the H₃ inverse agonist aims to evalute its ability to reduce cataplexy and improve symptoms in patients with narcolepsy type 1.Read Article

Emerging Considerations in Peripheral Nerve Injury and Surgical Intervention: Kevin Swong, MD

The neurosurgeon at Northwestern Medicine discussed diagnostic approaches, evolving treatment strategies, and the importance of timely referral in managing peripheral nerve injuries. [WATCH TIME: 3 minutes]Maryland · Maryland Read Article

Breaking News Topics Related to neurologylive.com